Trinidad and Tobago
Case Report
Case Reports on the Use of Intravenous Immunoglobulins (IVIG) in the
Treatment of Systemic Lupus Erythematosus (SLE)
Author(s): Angel Alberto Justiz Vaillant, Niurka Ramirez, Armando Cadiz and Patrick Eberechi AkpakaAngel Alberto Justiz Vaillant, Niurka Ramirez, Armando Cadiz and Patrick Eberechi Akpaka
Introduction: This work represents a preliminary study of the treatment of systemic lupus erythematosus with a commercially available intravenous immunoglobulin. The aim of this study was to assess the efficacy of this product in three patients aged 16, 34 and 49 diagnosed with systemic lupus erythematosus at the Internal Medicine Service of “Freire de Andrade” Hospital, Cuba. Case report summary: The patients had a history of treatment with several drugs, including immunesuppressants. However recurrent respiratory tract infections, skin rash as well as several immunological abnormalities were present. Intravenous immunoglobulin (5-10 g/day) was given intravenously during five consecutive days, in the absence of other types of immunotherapy. An immunological profile before and after the intravenous immunoglobulin therapy was performed. In addition the patients were clinica.. Read More»
DOI:
10.4172/2165-7920.1000263
Journal of Clinical Case Reports received 1295 citations as per Google Scholar report